HSGX Insider Trading Activity and SEC Form 4 Filings
HSGX insider trading summary
No open-market insider purchases or sales of Histogenics Corp (HSGX) have been reported on SEC Form 4 in the past 12 months.
Latest HSGX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 15, 2019 | Intrexon Corp | 10% Owner | Sell | $52K (345,897 @ $0.15) |
| Jan 15, 2019 | Randal J Kirk | 10% Owner | Sell | $52K (345,897 @ $0.15) |
| Jan 14, 2019 | Intrexon Corp | 10% Owner | Sell | $64K (400,507 @ $0.16) |
| Jan 14, 2019 | Randal J Kirk | 10% Owner | Sell | $64K (400,507 @ $0.16) |
| Jan 11, 2019 | Intrexon Corp | 10% Owner | Sell | $43K (251,800 @ $0.17) |
| Jan 11, 2019 | Randal J Kirk | 10% Owner | Sell | $43K (251,800 @ $0.17) |
| Oct 10, 2018 | Wilmslow Estates Ltd | 10% Owner | Buy | $0 (538,460 @ $0.00) |
| Oct 10, 2018 | Kevin Rakin | Director | Buy | $0 (230,768 @ $0.00) |
| Oct 10, 2018 | Michael Lewis | Director | Buy | $0 (538,460 @ $0.00) |
| May 16, 2018 | Adam Gridley | President and CEO | Buy | $4K (2,000 @ $2.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.